Haghighi Mehrvash, Packey Christopher, Gonda Tamas A
Department of Pathology, Columbia University Medical Center, 161, Fort Washington Avenue, New York, NY 10023, USA.
Department of Medicine, Columbia University Medical Center, 161, Fort Washington Avenue, New York, NY 10023, USA.
Gastrointest Endosc Clin N Am. 2017 Oct;27(4):601-614. doi: 10.1016/j.giec.2017.06.003. Epub 2017 Aug 7.
Significant advances have been made in the last few years in the technologies for sampling pancreatic masses, and in the understanding of the biology of pancreatic cancer. Better and more targeted treatments are likely to become available. Because most pancreatic cancers are likely to remain unresectable at diagnosis, high-quality, high-cellularity specimens are essential. A tailored approach that considers indication, location, and treatment possibilities needs to be taken before embarking on a pancreatic biopsy. Because the demand from oncologists and patients for increasingly personalized therapy is likely to grow, optimal sampling beyond diagnostic accuracy is likely to become increasingly critical.
在过去几年中,胰腺肿块采样技术以及对胰腺癌生物学的认识都取得了重大进展。更好、更具针对性的治疗方法可能会出现。由于大多数胰腺癌在诊断时可能仍无法切除,高质量、高细胞含量的标本至关重要。在进行胰腺活检之前,需要采取一种考虑适应证、位置和治疗可能性的定制方法。由于肿瘤学家和患者对日益个性化治疗的需求可能会增加,超越诊断准确性的最佳采样可能会变得越来越关键。